ASND
Ascendis Pharma A/S
$270.33−0.86 (−0.32%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Jan 28, 2015 – Nov 18, 2026, Dividends reinvested
- Final balance
- $143,563
- CAGR
- +25.32%
- Max drawdown
- −61.72%
Trailing returns (%)
ASND's average annual return was 29.33% over the last 10 years, through Nov 18, 2026. $10,000 in ASND on Nov 18, 2016 grew to $130,910 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +20.01%
- 3M
- +8.63%
- 6M
- +13.76%
- YTD
- +26.77%
- 1Y
- +24.50%
Per year
- 3Y
- +41.71%
- 5Y
- +12.71%
- 10Y
- +29.33%
- Since 2015
- +25.32%
Annual returns
2015 from Jan 28 · 2026 through Nov 18
ASND returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +26.77% |
| 2025 | +54.89% |
| 2024 | +9.31% |
| 2023 | +3.13% |
| 2022 | −9.22% |
| 2021 | −19.34% |
| 2020 | +19.88% |
| 2019 | +122.06% |
| 2018 | +56.39% |
| 2017 | +97.92% |
| 2016 | +10.48% |
| 2015 from Jan 28 | −2.71% |
Metrics
Since 2015| Volatility | 50.16% |
|---|---|
| Sharpe ratio | 0.69 |
| Sortino ratio | 1.15 |
| Calmar ratio | 0.41 |
| Longest drawdown | 4.6 years |
Worst drawdowns
Since 2015| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −61.7% | Dec 2020 | Apr 2023 | Aug 2025 | 4.6 years |
| −42.9% | Jul 2015 | Jun 2016 | Feb 2017 | 1.5 years |
| −33.1% | Feb 2020 | Mar 2020 | May 2020 | 3 months |
| −30.8% | Jun 2019 | Oct 2019 | Dec 2019 | 7 months |
| −27.7% | Aug 2018 | Dec 2018 | Mar 2019 | 6 months |